Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Online First
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
other Versions
You are currently viewing an
earlier version
of this article (October 05, 2020).
latest version (October 13, 2020).
View the most recent version of this article
PDF
Original research
Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer
Online download statistics by month:
Online download statistics by month: October 2020 to March 2024
Abstract
Full
Pdf
Oct 2020
435
19
14
Nov 2020
435
9
7
Dec 2020
138
13
9
Jan 2021
98
7
3
Feb 2021
75
2
1
Mar 2021
81
6
7
Apr 2021
77
2
1
May 2021
27
3
0
Jun 2021
4
2
1
Jul 2021
3
3
0
Aug 2021
2
2
1
Sep 2021
8
4
1
Oct 2021
86
1
4
Nov 2021
46
3
1
Dec 2021
62
0
0
Jan 2022
97
1
0
Feb 2022
72
0
0
Mar 2022
65
2
1
Apr 2022
33
0
0
May 2022
76
0
0
Jun 2022
90
2
0
Jul 2022
67
5
0
Aug 2022
82
4
1
Sep 2022
75
1
0
Oct 2022
118
2
0
Nov 2022
48
1
0
Dec 2022
44
3
2
Jan 2023
17
2
1
Feb 2023
115
2
0
Mar 2023
33
3
2
Apr 2023
40
0
0
May 2023
34
4
3
Jun 2023
56
2
1
Jul 2023
29
1
1
Aug 2023
118
1
1
Sep 2023
42
0
0
Oct 2023
70
4
3
Nov 2023
78
8
4
Dec 2023
77
6
4
Jan 2024
46
0
0
Feb 2024
40
0
0
Mar 2024
44
2
1
Total
3283
132
75
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?